pUltra BCR-ABL T315I V468F
(Plasmid
#210439)
-
PurposeLentiviral expression of BCR-ABL T315I V468F
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 210439 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepUltra
- Backbone size w/o insert (bp) 8327
-
Vector typeLentiviral
-
Selectable markersEGFP
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameBCR-ABL
-
SpeciesH. sapiens (human)
-
Insert Size (bp)6096
-
MutationT315I, V468F
-
Entrez GeneABL1 (a.k.a. ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl)
-
Entrez GeneBCR (a.k.a. ALL, BCR1, CML, D22S11, D22S662, PHL)
-
Tag
/ Fusion Protein
- EGFP-P2A (N terminal on backbone)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pUltra BCR-ABL T315I V468F was a gift from Justin Pritchard (Addgene plasmid # 210439 ; http://n2t.net/addgene:210439 ; RRID:Addgene_210439) -
For your References section:
A design approach for bitopic kinase inhibitors. Stevenson JW, Lou K, Reynolds JA, Outhwaite IR, Huang K, Sokirniy I, Peterson SYJ, Munir AZ, Wang CD, Inam H, Gebauer EL, Leyte-Vidal A, Grynyova A, Figueroa SM, Rees MG, Ronan MM, Salangsang F, Zeng Y, Steri V, Roth JA, Shah NP, Echeverria I, Šali A, Zhang Z, Moslehi JJ, Seeliger MA, Pritchard JR, Shokat KM. 2026, in press.